Profile
DYNT ABT BSX-PA BSX SYK MDT
Company Name Dynatronics Corporation Abbott Laboratories Boston Scientific Corporation Boston Scientific Corporation Stryker Corporation Medtronic plc
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices Medical - Devices
Market Cap $714.52K $233.05B $175.45B $155.01B $144.36B $106.66B
Employees 0.11K 114.00K 45.00K 53.00K 53.00K 95.00K
CEO Mr. Brian D. Baker Mr. Robert B. Ford Mr. Michael F. Mahoney Mr. Michael F. Mahoney Mr. Kevin A. Lobo Mr. Geoffrey Straub Martha
Ratings
DYNT ABT BSX-PA BSX SYK MDT
Quant Rating Score 3 4 3 3 3
Quant Rating Neutral Buy Neutral Neutral Neutral
Trading
DYNT ABT BSX-PA BSX SYK MDT
Last Close $0.0811 $133.95 $122.18 $104.8 $384.06 $83.16
High 52 $0.49 $140.22 $122.18 $106.18 $399.9 $94.5
Low 52 $0.08 $100.07 $122.18 $72.72 $315.94 $76.84
Price vs. 52 Week High -83.45 % -4.47 % 0 % -1.3 % -3.96 % -12 %
Price vs. 52 Week Low 1.38 % 33.86 % 0 % 44.11 % 21.56 % 8.22 %
Total Return
DYNT ABT BSX-PA BSX SYK MDT
1 Month Return -26.27 % 8.07 % 0 % 15.62 % 13.87 % 1.56 %
3 Month Return -35.63 % 4.61 % 0 % -0.95 % -1.88 % -7.61 %
6 Month Return -39.88 % 14.89 % 0 % 18.75 % 2.15 % -5.2 %
9 Month Return -52.29 % 22.04 % 0 % 38.72 % 17.81 % 1.16 %
YTD Return -33.09 % 18.42 % 0 % 17.33 % 6.67 % 4.11 %
1 Year Return -83.07 % 27.64 % 0 % 44.11 % 16.64 % 1.97 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
DYNT ABT BSX-PA BSX SYK MDT
Dividend Yield Percentage (TTM) - 1.7 % - - 0.87 % 3.37 %
Dividend Paid and Capex Coverage Ration (TTM) 6.16 % 1.57 % 3.96 % 3.96 % 2.2 % 1.34 %
Dividend Per Share (TTM) - 2.28 % - - 3.28 % 2.8 %
Payout Ratio (TTM) - 28.92 % 1.13 % 1.13 % 43.2 % 84.62 %
Growth
DYNT ABT BSX-PA BSX SYK MDT
Asset Growth -13.71 % 11.2 % 12.12 % 12.12 % -1.06 %
Gross Profit Growth -24.78 % 5.01 % 16.12 % 16.12 % 3.12 %
Revenue Growth -19.88 % 4.59 % 17.61 % 17.61 % 3.64 %
Revenue 3 Year -38.49 % -0.18 % 36.16 % 36.16 % 8.85 %
Revenue 5 Year -74.94 % 34.24 % 47.52 % 47.52 % 7.41 %
Revenue 10 Year -82.92 % 80.43 % 104.22 % 104.22 % 43.65 %
EBIT Growth 53.04 % 3.71 % 14.98 % 14.98 % -7.4 %
Net Income Growth 52.37 % 134.18 % 16.32 % 16.32 % -2.18 %
Net Income 3 Yeari Growth Per Share -301.62 % 94.27 % 72.05 % 72.05 % 3.26 %
Net Income 5 Yeari Growth Per Share 24.23 % 271.11 % -62.72 % -62.72 % -19.5 %
Net Income 10 Yeari Growth Per Share -43.35 % 410.99 % 524.58 % 524.58 % -9.48 %
Operating Income Growth 53.15 % 5.36 % 11.1 % 11.1 % -6.22 %
Operating Cash Flow Growth (CFG) -532.9 % 17.86 % 37.24 % 37.24 % 12.39 %
Operating 3 Year CFG -480 % -16.72 % 77.55 % 77.55 % 10.18 %
Operating 5 Year CFG -338.34 % 42.4 % 76.92 % 76.92 % -1.78 %
Operating 10 Year CFG -145.81 % 102.79 % 143.61 % 143.61 % 3.3 %
EPS Growth 31.51 % 134.55 % 16.67 % 16.67 % -2.12 %
EPS Diluted Growth 31.51 % 133.64 % 16.82 % 16.82 % -2.13 %
Book Value Per Share -4.97 % 23.54 % 11.25 % 11.25 % -2.26 %
Share Holder 3 Year Equity Growth Per Share -49.84 % 36.46 % 26.58 % 26.58 % -1.1 %
Share Holder 5 Year Equity Growth Per Share -67.12 % 56.53 % 48.35 % 48.35 % 1.66 %
Share Holder 10 Year Equity Growth Per Share -66.05 % 92.83 % 186.31 % 186.31 % 94.93 %
Dividend Per Share Growth - 8.02 % -100 % -100 % 1.54 %
Dividend 3 Year Growth Per Share -100 % 22.8 % -100 % -100 % 19.02 %
Dividend 5 Year Growth Per Share -100 % 72.53 % - - 38.05 %
Dividend 10 Year Growth Per Share - 148.92 % - - 147.94 %
Debt Growth 18.4 % -5.37 % 13.21 % 13.21 % 6.91 %
Free Cash Flow Growth -1101.2 % 25.54 % 55.31 % 55.31 % 13.54 %
Updated On 30 Jun 2024 31 Dec 2024 31 Dec 2024 31 Dec 2024 26 Apr 2024
Profitability
DYNT ABT BSX-PA BSX SYK MDT
Gross Profit Margin TTM 23.83 % 55.89 % 67.15 % 67.15 % 63.57 % 62.89 %
Return on Assets TTM -10.4 % 16.58 % 5.06 % 5.06 % 6.21 % 4.73 %
Return on Equity TTM -19.21 % 24.5 % 9.56 % 9.56 % 10.73 % 8.69 %
Return on Capital Employed TTM -12.38 % 10.5 % 8.77 % 8.77 % 9.61 % 7.74 %
Net Income Per EBT TTM 107.29 % 183.58 % 81.97 % 81.97 % 85.78 % 81.56 %
EBT Per Ebit TTM 121.92 % 102.35 % 80.59 % 80.59 % 91.04 % 86.39 %
EBIT Per Revenue TTM -6.85 % 16.97 % 17.52 % 17.52 % 15.77 % 18.21 %
Cash Flow To Debt Ratio TTM 2.21 % 67.59 % 32.56 % 32.56 % 29.81 % 27.41 %
Receivables Turnover TTM 9.88 - 6.52 6.52 5.86 5.43
Payables Turnover TTM 6.58 4.43 5.74 5.74 - 5.39
Inventory Turnover TTM 3.49 2.81 2.01 2.01 1.66 2.2
Fixed Asset Turnover TTM 672.24 % 387.34 % 517.94 % 517.94 % 656.62 % 503.55 %
Asset Turnover TTM 116.18 % 51.99 % 43.73 % 43.73 % 50.47 % 36.9 %
Operating Cash Flow Per Share TTM 0.02 5.12 2.58 2.58 11.23 5.69
Free Cash Flow Per Share TTM 0.02 3.81 1.94 1.94 9.37 4.26
Cash Per Share TTM 10.9 % 391.71 % 49.08 % 49.08 % 631.12 % 617.75 %
Operating Cash Flow Sales Ratio TTM 0.49 % 21.14 % 21.72 % 21.72 % 18.47 % 21.97 %
Free Cash Flow Operating Cash Flow Ratio TTM 83.78 % 74.38 % 75.37 % 75.37 % 83.42 % 74.96 %
Cash Flow Coverage Ratios TTM 2.21 % 67.59 % 32.56 % 32.56 % 29.81 % 27.41 %
Price To Free Cash Flows Ratio TTM 5.78 35.01 53.6 53.95 40.36 19.51
Price To Operating Cash Flows Ratio TTM 3.99 26.15 40.35 40.61 33.67 14.62
Price Cash Flow Ratio TTM 3.99 26.15 40.35 40.61 33.67 14.62
Income Statement (TTM)
DYNT ABT BSX-PA BSX SYK MDT
Revenue $0.03B $41.95B $16.75B $16.75B $22.6B $32.36B
Gross Profit $0.01B $23.24B $11.49B $11.49B $14.44B $21.15B
Gross Profit Ratio 23.47% 55.41% 68.61% 68.61% 63.91% 65.34%
EBITDA $-0B $10.83B $3.94B $3.94B $5.72B $8.2B
Net Income $-0B $13.4B $1.85B $1.85B $2.99B $3.68B
EPS Diluted -1 7.64 1.25 1.25 7.76 2.76
Balance Sheet (MRQ)
DYNT ABT BSX-PA BSX SYK MDT
Long Term Debt $0B $13.52B $8.84B $8.84B $12.19B $24.77B
Total Liabilities $0.01B $33.51B $17.39B $17.39B $22.34B $39.56B
Total Equity $0.01B $47.9B $22B $22B $20.63B $50.42B
Total Investments $0B $1.24B $0.56B $0.56B $0.84B $8.34B
Total Debt $0.01B $15.02B $11.15B $11.15B $13.6B $26.05B
Total Assets $0.03B $81.41B $39.4B $39.4B $42.97B $89.98B
Cash Flow Statement (TTM)
DYNT ABT BSX-PA BSX SYK MDT
Net Income $-0B $13.4B $1.85B $1.85B $2.99B $3.68B
Inventory $0B $-0.06B $-0.23B $-0.23B $0.05B $-0.14B
Dividends Paid $0B $-3.84B $0B $0B $-1.22B $-3.67B
Operating Cash Flow $-0B $8.56B $3.44B $3.44B $4.24B $6.79B
Capital Expenditure $-0B $-2.21B $-0.79B $-0.79B $-0.76B $-1.59B
Related Stocks
Ticker Name Price
ABMD Abiomed, Inc. 381.02
ABT Abbott Laboratories 133.98
ADGM Adagio Medical Holdings, Inc. 1.395
AEMD Aethlon Medical, Inc. 0.3642
AFIB Acutus Medical, Inc. 0.04
AHCO AdaptHealth Corp. 8.385
AHPI Allied Healthcare Products, Inc. 0.004
ALGN Align Technology, Inc. 180.915
ALUR Allurion Technologies Inc. 2.33
AMIX Autonomix Medical, Inc. Common Stock 1.69
ANIK Anika Therapeutics, Inc. 14.69
AORT Artivion, Inc. 28.48
APEN Apollo Endosurgery, Inc. 10
APYX Apyx Medical Corporation 1.19
ASXC Asensus Surgical, Inc. 0.3479
ATEC Alphatec Holdings, Inc. 12.745
AVNS Avanos Medical, Inc. 12.58
AVR Anteris Technologies Global Corp. Common Stock 4.4
AXDX Accelerate Diagnostics, Inc. 0.138
AXGN AxoGen, Inc. 12.5901
ETFs With Exposure to DYNT
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0 177.365
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 132.11
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 132.12
VEMPX Vanguard Extended Market Index InstlPlus 0 326.02
Unlock